25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

Vivesto AB
Buy, Hold or Sell?

Let's analyze Vivesto together

I guess you are interested in Vivesto AB. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Vivesto AB. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about Vivesto AB

I send you an email if I find something interesting about Vivesto AB.

1. Quick Overview

1.1. Quick analysis of Vivesto (30 sec.)










1.2. What can you expect buying and holding a share of Vivesto? (30 sec.)

How much money do you get?

How much money do you get?
kr0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
kr0.33
Expected worth in 1 year
kr0.15
How sure are you?
27.5%

+ What do you gain per year?

Total Gains per Share
kr-0.18
Return On Investment
-69.1%

For what price can you sell your share?

Current Price per Share
kr0.26
Expected price per share
kr0.217 - kr0.3165
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of Vivesto (5 min.)




Live pricePrice per Share (EOD)
kr0.26
Intrinsic Value Per Share
kr-1.18 - kr2.08
Total Value Per Share
kr-0.85 - kr2.42

2.2. Growth of Vivesto (5 min.)




Is Vivesto growing?

Current yearPrevious yearGrowGrow %
How rich?$16.6m$33.8m-$14.5m-75.6%

How much money is Vivesto making?

Current yearPrevious yearGrowGrow %
Making money-$2.3m-$7.8m$5.5m240.3%
Net Profit Margin0.0%-1,771.7%--

How much money comes from the company's main activities?

2.3. Financial Health of Vivesto (5 min.)




3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of Vivesto?

Welcome investor! Vivesto's management wants to use your money to grow the business. In return you get a share of Vivesto.

First you should know what it really means to hold a share of Vivesto. And how you can make/lose money.

Speculation

The Price per Share of Vivesto is kr0.263. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Vivesto.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Vivesto, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is kr0.33. Based on the TTM, the Book Value Change Per Share is kr-0.05 per quarter. Based on the YOY, the Book Value Change Per Share is kr-0.16 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is kr0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Vivesto.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 kr% of Price per Sharekr% of Price per Sharekr% of Price per Sharekr% of Price per Sharekr% of Price per Share
Usd Eps0.00-0.7%0.00-1.6%-0.01-2.6%-0.01-2.5%-0.01-2.4%
Usd Book Value Change Per Share0.00-0.7%0.00-1.6%-0.01-5.6%0.00-0.8%0.00-0.2%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share0.00-0.7%0.00-1.6%-0.01-5.6%0.00-0.8%0.00-0.2%
Usd Price Per Share0.03-0.03-0.04-0.22-0.40-
Price to Earnings Ratio-3.56--2.84--1.51--12.17--18.53-
Price-to-Total Gains Ratio-14.33--11.43--4.86--51.50--41.28-
Price to Book Ratio0.82-0.82-0.62-2.13-5.98-
Price-to-Total Gains Ratio-14.33--11.43--4.86--51.50--41.28-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share0.0244853
Number of shares40840
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share0.000.00
Usd Total Gains Per Share0.000.00
Gains per Quarter (40840 shares)-172.64-87.99
Gains per Year (40840 shares)-690.55-351.98
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-691-7010-352-362
20-1381-13920-704-714
30-2072-20830-1056-1066
40-2762-27740-1408-1418
50-3453-34650-1760-1770
60-4143-41560-2112-2122
70-4834-48470-2464-2474
80-5524-55380-2816-2826
90-6215-62290-3168-3178
100-6905-69200-3520-3530

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.04.00.00.0%0.012.00.00.0%1.019.00.05.0%1.039.00.02.5%2.059.00.03.3%
Book Value Change Per Share0.04.00.00.0%1.011.00.08.3%3.017.00.015.0%11.029.00.027.5%17.041.03.027.9%
Dividend per Share0.00.04.00.0%0.00.012.00.0%0.00.020.00.0%0.00.040.00.0%0.00.061.00.0%
Total Gains per Share0.04.00.00.0%1.011.00.08.3%3.017.00.015.0%11.029.00.027.5%17.041.03.027.9%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of Vivesto AB compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.019-0.045+137%-0.158+727%-0.023+21%-0.005-72%
Book Value Per Share--0.3330.384-13%0.675-51%0.929-64%0.794-58%
Current Ratio--3.1733.811-17%5.923-46%3.734-15%2.120+50%
Debt To Asset Ratio--0.0940.090+5%0.077+21%0.141-33%0.248-62%
Debt To Equity Ratio--0.1030.099+5%0.084+23%0.160-35%0.351-70%
Dividend Per Share----0%-0%-0%-0%
Eps---0.019-0.046+139%-0.073+281%-0.070+262%-0.068+254%
Free Cash Flow Per Share---0.017-0.026+54%-0.039+134%-0.062+268%-0.063+279%
Free Cash Flow To Equity Per Share---0.017-0.026+54%-0.041+148%-0.022+33%-0.007-59%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max--2.084--------
Intrinsic Value_10Y_min---1.181--------
Intrinsic Value_1Y_max---0.101--------
Intrinsic Value_1Y_min---0.232--------
Intrinsic Value_3Y_max---0.067--------
Intrinsic Value_3Y_min---0.603--------
Intrinsic Value_5Y_max--0.251--------
Intrinsic Value_5Y_min---0.868--------
Market Cap141505311.104-4%147423906.670165112085.253-11%232636345.584-37%1253002655.110-88%2316355869.609-94%
Net Profit Margin----0%-17.7170%-113.7580%-284.2390%
Operating Margin----0%-17.5790%-114.7490%-257.1150%
Operating Ratio----0%17.829-100%118.724-100%259.198-100%
Pb Ratio0.790-4%0.8230.8250%0.624+32%2.130-61%5.981-86%
Pe Ratio-3.414+4%-3.557-2.844-20%-1.510-58%-12.168+242%-18.532+421%
Price Per Share0.263-4%0.2740.307-11%0.432-37%2.329-88%4.305-94%
Price To Free Cash Flow Ratio-3.928+4%-4.092-3.375-18%-2.736-33%-6.328+55%-16.263+297%
Price To Total Gains Ratio-13.752+4%-14.327-11.428-20%-4.864-66%-51.499+259%-41.277+188%
Quick Ratio--2.6563.399-22%10.911-76%5.172-49%2.796-5%
Return On Assets---0.052-0.110+110%-0.222+322%-0.098+87%-0.081+55%
Return On Equity---0.058-0.122+111%-0.241+317%-0.096+66%-0.096+66%
Total Gains Per Share---0.019-0.045+137%-0.158+727%-0.023+21%-0.005-72%
Usd Book Value--16672161.80019258060.850-13%33811476.125-51%46539153.850-64%39777552.220-58%
Usd Book Value Change Per Share---0.002-0.004+137%-0.015+727%-0.002+21%-0.001-72%
Usd Book Value Per Share--0.0310.036-13%0.063-51%0.086-64%0.074-58%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Eps---0.002-0.004+139%-0.007+281%-0.006+262%-0.006+254%
Usd Free Cash Flow---838458.600-1293740.875+54%-1965666.850+134%-3086313.878+268%-3175807.416+279%
Usd Free Cash Flow Per Share---0.002-0.002+54%-0.004+134%-0.006+268%-0.006+279%
Usd Free Cash Flow To Equity Per Share---0.002-0.002+54%-0.004+148%-0.002+33%-0.001-59%
Usd Market Cap13174144.464-4%13725165.71115371935.137-11%21658443.774-37%116654547.191-88%215652731.461-94%
Usd Price Per Share0.024-4%0.0260.029-11%0.040-37%0.217-88%0.401-94%
Usd Profit---964702.200-2302409.550+139%-7835389.100+712%-4323666.410+348%-3826568.270+297%
Usd Revenue----0%23624.125-100%135348.780-100%97817.843-100%
Usd Total Gains Per Share---0.002-0.004+137%-0.015+727%-0.002+21%-0.001-72%
 EOD+3 -5MRQTTM+18 -11YOY+18 -135Y+20 -1110Y+15 -16

3.3 Fundamental Score

Let's check the fundamental score of Vivesto AB based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-3.414
Price to Book Ratio (EOD)Between0-10.790
Net Profit Margin (MRQ)Greater than00.000
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than12.656
Current Ratio (MRQ)Greater than13.173
Debt to Asset Ratio (MRQ)Less than10.094
Debt to Equity Ratio (MRQ)Less than10.103
Return on Equity (MRQ)Greater than0.15-0.058
Return on Assets (MRQ)Greater than0.05-0.052
Total5/10 (50.0%)

3.4 Technical Score

Let's check the technical score of Vivesto AB based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5056.878
Ma 20Greater thanMa 500.256
Ma 50Greater thanMa 1000.254
Ma 100Greater thanMa 2000.262
OpenGreater thanClose0.258
Total2/5 (40.0%)

4. In-depth Analysis

4.1 About Vivesto AB

Vivesto AB develops, produces, markets, and sells drugs in the field of human and veterinary oncology in Sweden. Its lead product is Apealea (paclitaxel micellar) for the treatment of ovarian cancer. The company's products portfolio includes Docetaxel micellar, a patented formulation that combines cytotoxin docetaxel with XR-17, which is in Phase 1b clinical trial for the treatment of prostate cancer; and Cantrixil to treat ovarian cancer. its animal health product portfolio includes Paccal Vet, a formulation of paclitaxel with its XR-17 encapsulation technology for the treatment of canine mastocytoma; and Doxophos Vet, a patented formulation of doxorubicin to treat lymphoma. The company was formerly known as Oasmia Pharmaceutical AB (publ) and changed its name to Vivesto AB in March 2022. Vivesto AB was incorporated in 1988 and is headquartered in Solna, Sweden.

Fundamental data was last updated by Penke on 2024-10-12 14:10:03.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is cheap.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profit Vivesto earns for each kr1 of revenue.

  • Above 10% is considered healthy but always compare Vivesto to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Net Profit Margin of 0.0% means that kr0.00 for each kr1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Vivesto AB:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-1,771.7%+1,771.7%
TTM-5Y-11,375.8%+11,375.8%
5Y-11,375.8%10Y-28,423.9%+17,048.1%
4.3.1.2. Return on Assets

Shows how efficient Vivesto is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Vivesto to the Drug Manufacturers - Specialty & Generic industry mean.
  • -5.2% Return on Assets means that Vivesto generated kr-0.05 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Vivesto AB:

  • The MRQ is -5.2%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -11.0%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-5.2%TTM-11.0%+5.8%
TTM-11.0%YOY-22.2%+11.1%
TTM-11.0%5Y-9.8%-1.2%
5Y-9.8%10Y-8.1%-1.6%
4.3.1.3. Return on Equity

Shows how efficient Vivesto is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Vivesto to the Drug Manufacturers - Specialty & Generic industry mean.
  • -5.8% Return on Equity means Vivesto generated kr-0.06 for each kr1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Vivesto AB:

  • The MRQ is -5.8%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -12.2%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-5.8%TTM-12.2%+6.4%
TTM-12.2%YOY-24.1%+11.9%
TTM-12.2%5Y-9.6%-2.6%
5Y-9.6%10Y-9.6%+0.0%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of Vivesto AB.

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

Measures how efficient Vivesto is operating .

  • Measures how much profit Vivesto makes for each kr1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Vivesto to the Drug Manufacturers - Specialty & Generic industry mean.
  • An Operating Margin of 0.0% means the company generated kr0.00  for each kr1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Vivesto AB:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-1,757.9%+1,757.9%
TTM-5Y-11,474.9%+11,474.9%
5Y-11,474.9%10Y-25,711.5%+14,236.5%
4.3.2.2. Operating Ratio

Measures how efficient Vivesto is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • An Operation Ratio of 0.00 means that the operating costs are kr0.00 for each kr1 in net sales.

Let's take a look of the Operating Ratio trends of Vivesto AB:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.000
TTM-YOY17.829-17.829
TTM-5Y118.724-118.724
5Y118.72410Y259.198-140.474
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of Vivesto AB.

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if Vivesto is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • A Current Ratio of 3.17 means the company has kr3.17 in assets for each kr1 in short-term debts.

Let's take a look of the Current Ratio trends of Vivesto AB:

  • The MRQ is 3.173. The company is very able to pay all its short-term debts. +2
  • The TTM is 3.811. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ3.173TTM3.811-0.638
TTM3.811YOY5.923-2.112
TTM3.8115Y3.734+0.077
5Y3.73410Y2.120+1.614
4.4.3.2. Quick Ratio

Measures if Vivesto is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Vivesto to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Quick Ratio of 2.66 means the company can pay off kr2.66 for each kr1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Vivesto AB:

  • The MRQ is 2.656. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 3.399. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ2.656TTM3.399-0.743
TTM3.399YOY10.911-7.512
TTM3.3995Y5.172-1.774
5Y5.17210Y2.796+2.376
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of Vivesto AB.

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much % of Vivesto assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Vivesto to Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Asset Ratio of 0.09 means that Vivesto assets are financed with 9.4% credit (debt) and the remaining percentage (100% - 9.4%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Vivesto AB:

  • The MRQ is 0.094. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.090. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.094TTM0.090+0.004
TTM0.090YOY0.077+0.012
TTM0.0905Y0.141-0.051
5Y0.14110Y0.248-0.108
4.5.4.2. Debt to Equity Ratio

Measures if Vivesto is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Vivesto to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Equity ratio of 10.3% means that company has kr0.10 debt for each kr1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Vivesto AB:

  • The MRQ is 0.103. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.099. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.103TTM0.099+0.005
TTM0.099YOY0.084+0.015
TTM0.0995Y0.160-0.062
5Y0.16010Y0.351-0.190
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every kr1 in earnings Vivesto generates.

  • Above 15 is considered overpriced but always compare Vivesto to the Drug Manufacturers - Specialty & Generic industry mean.
  • A PE ratio of -3.56 means the investor is paying kr-3.56 for every kr1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Vivesto AB:

  • The EOD is -3.414. Based on the earnings, the company is expensive. -2
  • The MRQ is -3.557. Based on the earnings, the company is expensive. -2
  • The TTM is -2.844. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-3.414MRQ-3.557+0.143
MRQ-3.557TTM-2.844-0.713
TTM-2.844YOY-1.510-1.334
TTM-2.8445Y-12.168+9.324
5Y-12.16810Y-18.532+6.364
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Vivesto AB:

  • The EOD is -3.928. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -4.092. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -3.375. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-3.928MRQ-4.092+0.164
MRQ-4.092TTM-3.375-0.718
TTM-3.375YOY-2.736-0.638
TTM-3.3755Y-6.328+2.953
5Y-6.32810Y-16.263+9.936
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price of Vivesto is to cheap or to expensive compared to its book value.

Let's take a look of the Price to Book Ratio trends of Vivesto AB:

  • The EOD is 0.790. Based on the equity, the company is cheap. +2
  • The MRQ is 0.823. Based on the equity, the company is cheap. +2
  • The TTM is 0.825. Based on the equity, the company is cheap. +2
Trends
Current periodCompared to+/- 
EOD0.790MRQ0.823-0.033
MRQ0.823TTM0.825-0.002
TTM0.825YOY0.624+0.201
TTM0.8255Y2.130-1.306
5Y2.13010Y5.981-3.851
4.6.2. Total Gains per Share
3rd party ad coffee SUPPORTERis ad-free.

6. Financial Statements




6.1. Latest Balance Sheet

Balance Sheet of 2024-06-30. Currency in SEK. All numbers in thousands.

Summary
Total Assets197,612
Total Liabilities18,534
Total Stockholder Equity179,078
 As reported
Total Liabilities 18,534
Total Stockholder Equity+ 179,078
Total Assets = 197,612

Assets

Total Assets197,612
Total Current Assets58,811
Long-term Assets138,801
Total Current Assets
Cash And Cash Equivalents 2,908
Short-term Investments 49,223
Total Current Assets  (as reported)58,811
Total Current Assets  (calculated)52,131
+/- 6,680
Long-term Assets
Intangible Assets 138,501
Long-term Assets  (as reported)138,801
Long-term Assets  (calculated)138,501
+/- 300

Liabilities & Shareholders' Equity

Total Current Liabilities18,534
Long-term Liabilities0
Total Stockholder Equity179,078
Total Current Liabilities
Accounts payable 5,484
Other Current Liabilities 673
Total Current Liabilities  (as reported)18,534
Total Current Liabilities  (calculated)6,157
+/- 12,377
Long-term Liabilities
Long-term Liabilities  (as reported)0
Long-term Liabilities  (calculated)0
+/-0
Total Stockholder Equity
Total Stockholder Equity (as reported)179,078
Total Stockholder Equity (calculated)0
+/- 179,078
Other
Capital Stock53,804
Common Stock Shares Outstanding 538,043
Net Invested Capital 179,078
Net Working Capital 40,277



6.2. Balance Sheets Structured

Currency in SEK. All numbers in thousands.

 Trend2024-06-302024-03-312023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-12-312011-09-302011-06-302011-03-312010-12-312010-09-302010-06-302010-03-312009-12-312009-09-302009-06-30
> Total Assets 
0
0
0
179,650
194,132
218,186
341,003
320,319
307,751
38,003
321,747
349,807
372,765
381,267
53,745
445,178
426,055
407,526
47,793
468,383
485,013
458,424
539,778
514,569
490,114
541,828
514,391
515,579
516,872
527,942
521,887
521,583
622,925
568,271
562,880
568,075
538,768
598,907
562,829
646,378
669,300
600,083
876,470
1,005,347
942,781
915,239
863,542
823,760
761,289
693,303
594,308
701,760
651,496
573,236
355,876
330,328
306,932
283,481
220,673
206,444
197,612
197,612206,444220,673283,481306,932330,328355,876573,236651,496701,760594,308693,303761,289823,760863,542915,239942,7811,005,347876,470600,083669,300646,378562,829598,907538,768568,075562,880568,271622,925521,583521,887527,942516,872515,579514,391541,828490,114514,569539,778458,424485,013468,38347,793407,526426,055445,17853,745381,267372,765349,807321,74738,003307,751320,319341,003218,186194,132179,650000
   > Total Current Assets 
0
0
0
10,076
2,737
3,441
98,257
56,889
23,849
5,077
8,933
6,227
18,557
7,295
11,327
69,895
44,052
18,252
2,954
54,276
66,310
35,735
114,792
86,690
56,444
103,745
71,824
72,570
73,031
58,365
50,947
50,119
149,927
94,256
76,280
80,509
49,547
105,942
67,891
151,368
176,046
107,489
384,735
532,215
473,820
455,386
416,079
350,382
289,074
228,322
136,495
250,842
207,859
180,177
150,318
127,701
107,534
87,772
80,275
66,844
58,811
58,81166,84480,27587,772107,534127,701150,318180,177207,859250,842136,495228,322289,074350,382416,079455,386473,820532,215384,735107,489176,046151,36867,891105,94249,54780,50976,28094,256149,92750,11950,94758,36573,03172,57071,824103,74556,44486,690114,79235,73566,31054,2762,95418,25244,05269,89511,3277,29518,5576,2278,9335,07723,84956,88998,2573,4412,73710,076000
       Cash And Cash Equivalents 
0
0
0
5,372
107
42
91,041
51,895
20,112
4,621
4,930
2,028
13,356
2,017
10,710
62,956
38,829
10,851
2,076
48,241
58,088
27,135
25,465
26,837
24,929
70,999
26,599
26,208
22,987
32,012
23,255
28,001
128,406
68,791
47,655
15,580
584
4,607
7,599
116,272
108,797
29,039
24,757
201,018
47,840
52,558
40,128
12,108
3,893
7,185
7,912
4,675
1,711
2,400
9,467
4,933
3,107
4,166
4,290
365
2,908
2,9083654,2904,1663,1074,9339,4672,4001,7114,6757,9127,1853,89312,10840,12852,55847,840201,01824,75729,039108,797116,2727,5994,60758415,58047,65568,791128,40628,00123,25532,01222,98726,20826,59970,99924,92926,83725,46527,13558,08848,2412,07610,85138,82962,95610,7102,01713,3562,0284,9304,62120,11251,89591,041421075,372000
       Short-term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
80,096
50,153
627
20,594
20,584
20,006
20,029
0
0
0
0
0
0
0
0
0
0
0
0
0
280,245
234,080
306,180
277,030
247,277
207,375
172,409
142,492
89,357
69,282
187,117
161,841
133,046
114,317
99,122
79,641
72,752
60,049
49,223
49,22360,04972,75279,64199,122114,317133,046161,841187,11769,28289,357142,492172,409207,375247,277277,030306,180234,080280,245000000000000020,02920,00620,58420,59462750,15380,0960000000000000000000000
       Net Receivables 
0
0
0
2,150
1,326
1,938
3,075
2,141
1,289
159
1,611
1,747
1,666
2,311
2,490
2,314
1,946
2,756
364
2,778
4,219
4,282
4,723
0
0
3,230
8,621
6,832
13,098
0
-12,846
0
0
0
16,754
0
37,731
0
0
22,147
0
61,967
0
0
0
0
0
0
0
0
10,101
9,737
982
1,322
1,259
1,540
1,805
361
69
50
0
050693611,8051,5401,2591,3229829,73710,1010000000061,967022,1470037,731016,754000-12,846013,0986,8328,6213,230004,7234,2824,2192,7783642,7561,9462,3142,4902,3111,6661,7471,6111591,2892,1413,0751,9381,3262,150000
       Other Current Assets 
0
0
0
2,460
-1
1
4,047
2,853
2,448
-1
2,102
1
2,648
2,080
1
1
2,390
2,792
327
1,601
-1
1,550
1,852
4,359
0
1
3,317
1
-1
10,408
23,255
8,433
8,071
12,569
1
55,183
-1
90,194
47,685
1
57,699
-1
61,348
68,280
88,519
76,447
0
79,577
84,453
62,449
-1
157,251
9,135
6,587
-1
0
0
0
0
0
0
000000-16,5879,135157,251-162,44984,45379,577076,44788,51968,28061,348-157,699147,68590,194-155,183112,5698,0718,43323,25510,408-113,317104,3591,8521,550-11,6013272,7922,390112,0802,64812,102-12,4482,8534,0471-12,460000
   > Long-term Assets 
0
0
0
169,574
191,395
214,745
242,746
263,430
283,902
32,926
312,814
343,580
354,208
373,972
42,418
375,283
382,003
389,274
44,839
414,106
418,702
422,689
424,986
427,879
34,957
438,084
442,568
443,010
443,841
469,577
470,940
471,464
472,998
474,015
486,600
487,565
489,220
492,965
494,938
495,010
493,254
492,595
491,735
473,132
468,961
459,853
27,129
473,379
472,215
464,981
457,813
450,918
443,637
393,059
205,558
202,627
199,398
195,709
140,398
139,600
138,801
138,801139,600140,398195,709199,398202,627205,558393,059443,637450,918457,813464,981472,215473,37927,129459,853468,961473,132491,735492,595493,254495,010494,938492,965489,220487,565486,600474,015472,998471,464470,940469,577443,841443,010442,568438,08434,957427,879424,986422,689418,702414,10644,839389,274382,003375,28342,418373,972354,208343,580312,81432,926283,902263,430242,746214,745191,395169,574000
       Property Plant Equipment 
0
0
0
20,665
22,687
25,565
26,954
27,243
27,706
2,971
26,031
25,988
26,694
28,165
3,154
26,161
25,182
24,243
2,648
24,401
24,783
24,282
23,953
22,852
23,112
22,795
22,001
21,172
20,619
19,827
19,147
18,368
17,685
16,872
16,133
15,527
14,710
14,524
14,950
14,701
37,875
37,415
35,941
28,014
28,937
24,924
17,630
15,604
20,136
18,593
17,108
15,895
14,296
12,998
12,964
12,408
11,557
10,247
17,456
0
0
0017,45610,24711,55712,40812,96412,99814,29615,89517,10818,59320,13615,60417,63024,92428,93728,01435,94137,41537,87514,70114,95014,52414,71015,52716,13316,87217,68518,36819,14719,82720,61921,17222,00122,79523,11222,85223,95324,28224,78324,4012,64824,24325,18226,1613,15428,16526,69425,98826,0312,97127,70627,24326,95425,56522,68720,665000
       Intangible Assets 
0
0
0
148,907
168,706
189,179
215,790
236,185
256,194
29,954
286,781
0
27,533
0
39,264
349,120
356,819
365,030
42,191
389,704
393,917
398,405
401,031
405,026
11,843
415,287
420,564
421,836
423,221
449,748
451,791
453,093
455,311
457,141
470,465
472,036
474,508
478,439
479,986
478,306
453,376
453,178
453,792
443,116
438,021
432,926
9,197
457,472
451,777
446,087
440,404
434,722
429,040
379,760
192,293
189,918
187,540
185,161
140,098
139,300
138,501
138,501139,300140,098185,161187,540189,918192,293379,760429,040434,722440,404446,087451,777457,4729,197432,926438,021443,116453,792453,178453,376478,306479,986478,439474,508472,036470,465457,141455,311453,093451,791449,748423,221421,836420,564415,28711,843405,026401,031398,405393,917389,70442,191365,030356,819349,12039,264027,5330286,78129,954256,194236,185215,790189,179168,706148,907000
       Other Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1
1
0
0
0
398,713
-1
-1
-1
0
0
0
0
0
0
0
1
1
0
0
0
0
-1
0
0
0
0
420,334
-1
0
0
0
0
0
342,550
338,435
156,832
155,253
0
0
0
0
0000155,253156,832338,435342,55000000-1420,3340000-10000110000000-1-1-1398,713000110000000000000000000
> Total Liabilities 
0
0
0
37,847
64,419
105,202
25,319
26,148
28,840
3,566
28,536
76,333
118,615
141,681
14,063
126,025
125,126
125,258
19,327
186,476
189,264
189,389
133,987
138,858
154,208
181,008
171,885
189,526
227,288
225,923
218,655
221,213
216,917
175,838
199,050
223,039
216,970
197,970
163,482
222,333
241,183
192,987
153,785
185,958
173,977
201,642
176,800
184,163
178,617
141,234
44,595
43,750
34,309
27,741
30,452
25,348
30,136
22,312
22,874
17,076
18,534
18,53417,07622,87422,31230,13625,34830,45227,74134,30943,75044,595141,234178,617184,163176,800201,642173,977185,958153,785192,987241,183222,333163,482197,970216,970223,039199,050175,838216,917221,213218,655225,923227,288189,526171,885181,008154,208138,858133,987189,389189,264186,47619,327125,258125,126126,02514,063141,681118,61576,33328,5363,56628,84026,14825,319105,20264,41937,847000
   > Total Current Liabilities 
0
0
0
22,443
49,015
89,798
9,915
10,775
12,576
1,764
12,272
60,069
102,351
17,964
13,959
125,134
124,235
124,367
19,226
185,584
188,372
188,498
133,987
138,858
154,208
87,849
171,885
189,527
227,289
225,923
218,655
221,212
216,918
175,838
199,049
223,039
216,970
165,148
130,660
189,510
195,779
181,720
143,612
177,112
166,480
195,344
176,800
180,818
171,685
135,246
39,454
39,423
30,547
24,299
25,271
20,592
26,055
18,889
22,874
17,076
18,534
18,53417,07622,87418,88926,05520,59225,27124,29930,54739,42339,454135,246171,685180,818176,800195,344166,480177,112143,612181,720195,779189,510130,660165,148216,970223,039199,049175,838216,918221,212218,655225,923227,289189,527171,88587,849154,208138,858133,987188,498188,372185,58419,226124,367124,235125,13413,95917,964102,35160,06912,2721,76412,57610,7759,91589,79849,01522,443000
       Short-term Debt 
0
0
0
14,839
41,535
74,251
0
0
0
0
0
32,797
90,000
4,651
12,178
105,000
105,000
105,000
16,391
145,000
145,000
145,000
107,000
107,000
0
20,035
114,430
139,944
176,829
163,515
164,853
168,726
160,806
138,194
161,274
187,260
168,445
123,387
85,786
139,568
140,798
80,000
80,000
85,321
85,345
85,795
0
82,833
83,646
86,129
5,287
3,412
3,054
2,802
2,987
3,137
2,897
0
0
0
0
00002,8973,1372,9872,8023,0543,4125,28786,12983,64682,833085,79585,34585,32180,00080,000140,798139,56885,786123,387168,445187,260161,274138,194160,806168,726164,853163,515176,829139,944114,43020,0350107,000107,000145,000145,000145,00016,391105,000105,000105,00012,1784,65190,00032,7970000074,25141,53514,839000
       Accounts payable 
0
0
0
2,076
612
8,455
3,896
3,831
5,044
795
5,533
10,281
3,138
6,991
514
7,084
3,823
4,052
815
17,503
17,125
16,367
12,531
14,017
23,032
40,957
37,728
27,236
22,855
35,201
20,411
20,837
19,147
15,363
10,374
9,256
15,541
14,820
17,032
17,666
13,910
14,516
14,228
22,524
13,929
17,864
10,678
12,401
8,016
6,186
13,590
4,540
8,065
6,547
7,000
1,950
4,766
3,481
2,758
1,907
5,484
5,4841,9072,7583,4814,7661,9507,0006,5478,0654,54013,5906,1868,01612,40110,67817,86413,92922,52414,22814,51613,91017,66617,03214,82015,5419,25610,37415,36319,14720,83720,41135,20122,85527,23637,72840,95723,03214,01712,53116,36717,12517,5038154,0523,8237,0845146,9913,13810,2815,5337955,0443,8313,8968,4556122,076000
       Other Current Liabilities 
0
0
0
1,196
1,449
1,312
1,457
1,399
1,325
167
1,556
10,811
1,559
1,505
183
1,566
1,615
1,691
163
1,593
1,622
1,645
1,817
1,796
131,176
2,044
2,332
21,430
2,571
2,159
2,496
196
16,153
3,358
3,844
3,504
3,248
3,371
3,309
3,216
8,248
53,273
8,853
116
3,910
5,530
166,122
4,096
2,823
4,942
267
31,471
19,428
14,950
15,284
15,505
2,203
1,037
799
1,525
673
6731,5257991,0372,20315,50515,28414,95019,42831,4712674,9422,8234,096166,1225,5303,9101168,85353,2738,2483,2163,3093,3713,2483,5043,8443,35816,1531962,4962,1592,57121,4302,3322,044131,1761,7961,8171,6451,6221,5931631,6911,6151,5661831,5051,55910,8111,5561671,3251,3991,4571,3121,4491,196000
   > Long-term Liabilities 
0
0
0
15,404
15,404
15,404
15,404
15,373
16,264
1,802
16,264
16,264
16,264
123,717
104
891
891
891
101
892
892
891
119,531
121,018
0
93,159
152,158
-1
-1
198,716
185,264
1
-1
153,557
1
196,516
183,986
32,822
32,822
32,823
45,404
11,267
10,173
8,846
7,497
6,298
0
3,345
6,932
5,988
5,141
4,327
3,762
3,442
5,181
4,756
4,081
3,423
0
0
0
0003,4234,0814,7565,1813,4423,7624,3275,1415,9886,9323,34506,2987,4978,84610,17311,26745,40432,82332,82232,822183,986196,5161153,557-11185,264198,716-1-1152,15893,1590121,018119,531891892892101891891891104123,71716,26416,26416,2641,80216,26415,37315,40415,40415,40415,404000
       Deferred Long Term Liability 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
342,550
338,435
156,832
155,253
0
0
0
0
0000155,253156,832338,435342,55000000000000000000000000000000000000000000000000000000
> Total Stockholder Equity
0
0
0
141,746
129,657
112,929
315,632
294,171
278,911
34,437
293,211
273,474
254,150
239,586
39,682
319,153
300,929
282,268
28,466
281,907
295,749
269,035
405,791
375,711
-515,104
360,820
342,506
326,053
289,584
302,019
303,232
300,370
406,008
392,436
363,868
345,042
321,812
400,951
399,347
424,045
428,117
407,096
722,685
819,389
768,804
713,597
-1,223,820
639,597
582,672
552,069
549,713
658,010
617,187
545,495
325,424
304,980
276,796
261,169
197,799
189,368
179,078
179,078189,368197,799261,169276,796304,980325,424545,495617,187658,010549,713552,069582,672639,597-1,223,820713,597768,804819,389722,685407,096428,117424,045399,347400,951321,812345,042363,868392,436406,008300,370303,232302,019289,584326,053342,506360,820-515,104375,711405,791269,035295,749281,90728,466282,268300,929319,15339,682239,586254,150273,474293,21134,437278,911294,171315,632112,929129,657141,746000
   Common Stock
0
0
0
3,761
3,761
3,761
5,208
5,208
5,208
634
5,724
5,724
5,724
5,724
948
8,177
8,177
8,177
924
8,557
8,807
8,807
9,786
9,786
9,786
9,786
10,554
10,721
10,721
10,721
11,904
11,904
17,288
17,641
17,641
17,641
17,931
19,439
20,052
22,490
24,909
24,909
44,837
44,837
44,837
44,837
44,837
44,837
44,837
44,837
44,837
49,674
53,804
53,804
53,804
53,804
53,804
0
0
0
0
000053,80453,80453,80453,80453,80449,67444,83744,83744,83744,83744,83744,83744,83744,83744,83724,90924,90922,49020,05219,43917,93117,64117,64117,64117,28811,90411,90410,72110,72110,72110,5549,7869,7869,7869,7868,8078,8078,5579248,1778,1778,1779485,7245,7245,7245,7246345,2085,2085,2083,7613,7613,761000
   Retained Earnings Total Equity0000000000000000000000000000000000000000000000000000000000000
   Accumulated Other Comprehensive Income 000000000000000000000000000000000-19-5-70000000000000000000000000
   Capital Surplus 0000000000000000000000000000000000000000000000000000000000000
   Treasury Stock0000000000000000000000000000000000000000000000000000000000000
   Other Stockholders Equity 
0
0
0
196,494
196,493
196,493
413,375
413,374
413,375
50,769
457,832
457,832
457,831
457,831
66,513
573,439
573,439
573,439
64,820
640,924
687,506
687,506
850,996
850,996
515,104
919,327
925,585
941,961
942,394
996,172
1,036,099
1,075,319
1,207,286
1,218,451
1,218,968
1,232,261
1,241,263
1,379,876
1,407,931
1,478,862
1,551,310
1,548,743
1,903,616
1,902,938
1,905,459
1,903,790
1,223,820
1,904,626
1,905,378
1,905,762
1,906,255
2,036,172
2,029,733
2,029,723
2,029,718
2,029,703
2,029,701
0
0
0
0
00002,029,7012,029,7032,029,7182,029,7232,029,7332,036,1721,906,2551,905,7621,905,3781,904,6261,223,8201,903,7901,905,4591,902,9381,903,6161,548,7431,551,3101,478,8621,407,9311,379,8761,241,2631,232,2611,218,9681,218,4511,207,2861,075,3191,036,099996,172942,394941,961925,585919,327515,104850,996850,996687,506687,506640,92464,820573,439573,439573,43966,513457,831457,831457,832457,83250,769413,375413,374413,375196,493196,493196,494000



6.3. Balance Sheets

Currency in SEK. All numbers in thousands.




6.4. Cash Flows

Currency in SEK. All numbers in thousands.




6.5. Income Statements

Currency in SEK. All numbers in thousands.


6.6. Latest Income Statement

Income Statement (annual), 2023-12-31. Currency in SEK. All numbers in thousands.

Gross Profit (+$)
totalRevenue0
Cost of Revenue-0
Gross Profit00
 
Operating Income (+$)
Gross Profit0
Operating Expense-138,808
Operating Income-138,808-138,808
 
Operating Expense (+$)
Research Development0
Selling General Administrative0
Selling And Marketing Expenses0
Operating Expense138,8080
 
Net Interest Income (+$)
Interest Income5
Interest Expense-0
Other Finance Cost-0
Net Interest Income5
 
Pretax Income (+$)
Operating Income-138,808
Net Interest Income5
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-128,740-138,808
EBIT - interestExpense = 0
-128,740
-128,740
Interest Expense0
Earnings Before Interest and Taxes (EBIT)0-128,740
Earnings Before Interest and Taxes (EBITDA)0
 
After tax Income (+$)
Income Before Tax-128,740
Tax Provision-0
Net Income From Continuing Ops-128,740-128,740
Net Income-128,740
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses0
Total Other Income/Expenses Net0-5
 

Technical Analysis of Vivesto
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Vivesto. The general trend of Vivesto is BEARISH with 28.6% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Vivesto's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-28.6%) Bearish trend (28.6%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Vivesto AB.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is -1/(-1 +1).

  • Around resistance: The price is trading arround resistance levels. This can be considered as a potential exit level. -1

The bullish price targets are: 0.269 < 0.312 < 0.3165.

The bearish price targets are: 0.246 > 0.22 > 0.217.

Tweet this
Vivesto AB Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Vivesto AB. The current mas is .

The long score for the Moving Averages is 5/14.
The longshort score for the Moving Averages is -4/(-14 +14).

  • MA 20 trending up: The MA 20 is trending up. +1
  • Close > MA 20: The price is above the MA 20. +1
  • MA 20 > MA 50: The MA 20 is higher than the MA 50. +1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close > MA 50: The price is above the MA 50. +1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close > MA 100: The price is above the MA 100. +1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Vivesto AB Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Vivesto AB. The current macd is 0.00318867.

The long score for the Moving Average Convergence/Divergence (MACD) is 4/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 4/(-4 +4).

  • MACD line > signal line: The MACD line is above the signal line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Vivesto price going up in the near term. +2
  • MACD > 0: The MACD is above the zero line (centerline), it indicates a bullish signal for Vivesto. This means that the short-term moving average is higher than the long-term moving average, signaling positive momentum and suggesting a higher likelihood of the Vivesto price continuing to rise in the near future. It indicates that buyers are gaining control, and there is optimism in the market, leading to potential price increases. +1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
Vivesto AB Daily Moving Average Convergence/Divergence (MACD) ChartVivesto AB Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Vivesto AB. The current adx is 17.69.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -1/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell Vivesto shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX < 25 && ADX trending down: The ADX is below 25 and indicates a weak or no trend. Also, the ADX is declining so there is no trend indication.
Vivesto AB Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Vivesto AB. The current sar is 0.24799947.

The long score for the Parabolic SAR is 1/1.
The longshort score for the Parabolic SAR is 1/(-1 +1).

  • Close > SAR: The price is above the SAR. It's generally considered a bullish signal. +1
Vivesto AB Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Vivesto AB. The current rsi is 56.88. The current phase is Correction in bear market.

The long score for the Relative Strength Index (RSI) is 4/13.
The longshort score for the Relative Strength Index (RSI) is 4/(-13 +13).

  • Correction in bear market: Extended price decline in a downtrend, significant pullback. Consider reducing exposure, wait for signs of trend reversal.
  • Trending up: The RSI is trending up. +1
Vivesto AB Daily Relative Strength Index (RSI) ChartVivesto AB Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Vivesto AB. The current phase is Continuation in bear market.

The long score for the Stochastic Oscillator is 1/6.
The longshort score for the Stochastic Oscillator is -1/(-6 +6).

  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Vivesto price going down in the near term. -2
  • Trending up: The STOCH %K is trending up. +1
Vivesto AB Daily Stochastic Oscillator ChartVivesto AB Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Vivesto AB. The current cci is 84.10.

Vivesto AB Daily Commodity Channel Index (CCI) ChartVivesto AB Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Vivesto AB. The current cmo is 16.44.

The long score for the Chande Momentum Oscillator (CMO) is 1/1.
The longshort score for the Chande Momentum Oscillator (CMO) is 1/(-1 +1).

  • CMO > 0: The CMO is above 0, the momentum of the price is positive, indicating a potential uptrend in the price. +1
Vivesto AB Daily Chande Momentum Oscillator (CMO) ChartVivesto AB Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Vivesto AB. The current willr is -50.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that Vivesto is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
Vivesto AB Daily Williams %R ChartVivesto AB Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Vivesto AB.

Vivesto AB Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Vivesto AB. The current atr is 0.01343336.

Vivesto AB Daily Average True Range (ATR) ChartVivesto AB Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Vivesto AB. The current obv is -52,604,193.

Vivesto AB Daily On-Balance Volume (OBV) ChartVivesto AB Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Vivesto AB. The current mfi is 67.07.

The long score for the Money Flow Index (MFI) is 1/2.
The longshort score for the Money Flow Index (MFI) is 1/(-2 +2).

  • MFI > 50: +1
Vivesto AB Daily Money Flow Index (MFI) ChartVivesto AB Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Vivesto AB.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2024-06-17MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-06-18CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-06-19WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-06-20STOCH SHORT EXITThe %K line crosses above the %D line.
2024-06-24STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-06-26STOCH SHORT EXITThe %K line crosses above the %D line.
2024-07-01DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-07-03SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-07-05STOCH SHORT EXITThe %K line crosses above the %D line.
2024-07-08STOCH LONG EXITThe %K line crosses below the %D line.
2024-07-09STOCH SHORT EXITThe %K line crosses above the %D line.
2024-07-12MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-07-15CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-07-16STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-07-19STOCH SHORT EXITThe %K line crosses above the %D line.
2024-07-22STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-07-24STOCH SHORT EXITThe %K line crosses above the %D line.
2024-07-26STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-07-29CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-07-30STOCH SHORT EXITThe %K line crosses above the %D line.
2024-08-05DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-08-06MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-08-07MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-08-09STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-08-13CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-08-14STOCH SHORT EXITThe %K line crosses above the %D line.
2024-08-15MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-08-16MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-08-19BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-08-21STOCH SHORT EXITThe %K line crosses above the %D line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-08-22SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
2024-08-23CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-08-29MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-09-03STOCH SHORT EXITThe %K line crosses above the %D line.
2024-09-05STOCH LONG EXITThe %K line crosses below the %D line.
2024-09-06STOCH SHORT EXITThe %K line crosses above the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-09-09STOCH LONG EXITThe %K line crosses below the %D line.
2024-09-11STOCH SHORT EXITThe %K line crosses above the %D line.
2024-09-13WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-09-16MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-09-18STOCH LONG EXITThe %K line crosses below the %D line.
2024-09-19MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-09-23STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-09-24MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-09-27STOCH SHORT EXITThe %K line crosses above the %D line.
2024-10-01STOCH LONG EXITThe %K line crosses below the %D line.
2024-10-02STOCH SHORT EXITThe %K line crosses above the %D line.
2024-10-04STOCH LONG EXITThe %K line crosses below the %D line.
2024-10-07SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-10-08MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-10-14WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-10-16STOCH LONG EXITThe %K line crosses below the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-10-18STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-10-21STOCH LONG EXITThe %K line crosses below the %D line.
2024-10-23DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-10-24CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-10-25DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-10-28DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-10-31DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.

6.3. Candlestick Patterns

Vivesto AB Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Vivesto AB based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5056.878
Ma 20Greater thanMa 500.256
Ma 50Greater thanMa 1000.254
Ma 100Greater thanMa 2000.262
OpenGreater thanClose0.258
Total2/5 (40.0%)
Penke
Good job! You gained 25 XP and 0   0   10 . What's next:
  • Share my analysis of Vivesto with someone you think should read this too:
  • Are you bullish or bearish on Vivesto? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Vivesto? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Vivesto AB

I send you an email if I find something interesting about Vivesto AB.


Comments

How you think about this?

Leave a comment

Stay informed about Vivesto AB.

Receive notifications about Vivesto AB in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.